潰瘍性大腸炎における炎症シグナル伝達経路の転写プロファイルの識別
Salvia Misaghian1, M Saleet Jafri1,2
1School of Systems Biology, George Mason University, Fairfax, Virginia, United States of America.
PloS one
|September 2, 2025
まとめ
この研究は,慢性炎症性腸疾患である潰瘍性大腸炎 (UC) の重要な遺伝子を明らかにしています. PLCB3のダウン調節とDUOX2のアップ調節は,UCの潜在的診断および治療目標を提供します.
科学分野:
- ゲノミクス
- 分子生物学
- 免疫学
背景:
- 潰瘍性大腸炎 (UC) は,複雑な分子基盤を持つ慢性炎症性腸疾患 (IBD) である.
- 核遺伝子と経路を特定することは,UCの病原性を理解し,標的治療法を開発するために不可欠です.
研究 の 目的:
- 潰瘍性大腸炎 (UC) の病原性に関与する核心遺伝子と経路を特定する.
- PLCB3 と DUOX2 といった特定の遺伝子のUC発達の役割を調査する.
- UCの潜在的な診断と治療のターゲットを探求する.
主な方法:
- 129人のUC患者と73人の健康な対照群からの結腸生検の転写プロファイリング.
- 遺伝子表現オムニバス (GEO) のマイクロアレイデータを用いて40,991の遺伝子を分析した.
- 差異性遺伝子発現 (DGE) 分析と遺伝子セット濃縮分析 (GSEA)
主要な成果:
- PLCB3はUCにおいて著しく低下し,腸内ホメオスタシスの維持に作用することを示唆した.
- 炎症反応と酸化ストレスへの関与を示した.
- 経路分析はPLCB3を脂質代謝とNF- kBシグナル伝達と関連付け,DUOX2は反応性酸素種とケモカインシグナル伝達と関連付けました.
結論:
- PLCB3とDUOX2はUCにおける重要な分子であり,腸内ホメオスタシスと炎症に影響を与えます.
- PLCB3とDUOX2の相互作用は,UCの病原性に対する両者の影響を強調しています.
- これらの発見は,潰瘍性大腸炎の潜在的なバイオマーカーと治療標的を特定します.
関連する概念動画
Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
Inflammatory Bowel Disease II: Crohn's Disease
375
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
375
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K


